Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207,566 | 259,406 | 224,153 | 189,746 | 182,331 |
| Marketable Securities | N/A | 10,857 | 10,506 | 13,301 | 13,156 |
| Receivables | 201,794 | 128,601 | 124,978 | 119,916 | 111,514 |
| Inventories | 61,914 | 55,572 | 54,676 | 53,050 | 52,370 |
| Other current assets | 39,032 | 10,924 | 10,297 | 10,356 | 11,517 |
| TOTAL | $510,306 | $465,360 | $424,610 | $386,369 | $370,888 |
| Non-Current Assets | |||||
| PPE Net | 357,149 | 209,193 | 205,885 | 207,309 | 203,458 |
| Intangibles | 1,678,880 | 145,984 | 145,849 | 147,671 | 135,723 |
| Other Non-Current Assets | 80,500 | 86,511 | 86,040 | 84,477 | 89,485 |
| TOTAL | $2,116,529 | $441,688 | $437,774 | $439,457 | $428,666 |
| Total Assets | $2,626,835 | $907,048 | $862,384 | $825,826 | $799,554 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 80,865 | N/A | N/A | N/A | 319 |
| Accounts payable and accrued liabilities | 28,672 | 15,487 | 16,451 | 16,227 | 19,433 |
| Accrued Expenses | 97,759 | 67,809 | 62,193 | 57,597 | 56,094 |
| Other current liabilities | 24,329 | 15,451 | 10,114 | 3,791 | 7,659 |
| TOTAL | $349,115 | $136,068 | $122,361 | $110,714 | $114,351 |
| Non-Current Liabilities | |||||
| Long Term Debt | 605,980 | 185,961 | 186,137 | 186,229 | 185,683 |
| Deferred Revenues | 117,490 | 37,321 | 33,603 | 33,099 | 30,846 |
| Other Non-Current Liabilities | 199,235 | 34,195 | 34,824 | 34,884 | 34,897 |
| TOTAL | $805,215 | $220,156 | $220,961 | $221,113 | $220,580 |
| Total Liabilities | $1,154,330 | $356,224 | $343,322 | $331,827 | $334,931 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,110 | 64,803 | 46,205 | 46,127 | 46,075 |
| Common Shares | 658 | 463 | 462 | 461 | 458 |
| Retained earnings | -63,093 | -83,170 | -108,991 | -135,291 | -152,885 |
| Other shareholders' equity | 16,086 | 7,972 | 5,414 | 10,101 | 7,269 |
| TOTAL | $1,472,505 | $550,824 | $519,062 | $493,999 | $464,623 |
| Total Liabilities And Equity | $2,626,835 | $907,048 | $862,384 | $825,826 | $799,554 |